Loading...

Landec Corporation

LNDCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.76
$-0.32(-3.52%)

Landec Corporation (LNDC) Stock Overview

Explore Landec Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.7/100

Key Financials

Market Cap263.6M
P/E Ratio21.08
EPS (TTM)$-2.17
ROE2.28%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$7.86

LNDC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Landec Corporation (LNDC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $7.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.08 and a market capitalization of 263.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
24.20%
24.20%
Profit Growth
$0.42
111.76%
EPS Growth
$0.42
111.44%
Operating Margin
47.96%
135.77%
ROE
227.93%
111.76%
Dividend Yield
0.00%
Analyst Recommendations data is not available for LNDCAnalyst Recommendations details for LNDC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

CEO

Albert Bolles

Employees

689

Headquarters

5201 Great America Pkwy Ste 232, Santa Clara, CA

Founded

1996

Frequently Asked Questions

;